Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

The large UK Biobank study finds depression a significant risk predictor for developing chronic conditions such as osteoarthritis, hypertension, and gastro-oesophageal reflux disease.

Dignity Health Hypertension, or high blood pressure, is a prevalent condition in the United States, affecting nearly half of adults and significantly increasing the risk of heart ...

Frailty nurse specialist Linda Nazarko advises on what nurses in general practice need to be aware of when reviewing and ...

Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. Read more to ...

Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the risk factors associated with ...

Cardiac and pulmonary wellness dietitian Sheri Gaw tells Yahoo LIfe that “salt alternatives are especially helpful for people ...

Postpartum patients with hypertension who were prescribed nifedipine at discharge had an 88% lower readmission rate than ...

"People who suffer from sickle cell have challenges that I don't believe we all know," Philpart said. "Sometimes it gets lost ...

Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...

Natco Pharma said that it has received final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), which is a generic version of Tracleer by Actelion Pharmaceuticals US Inc.

Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for ...